IBUTILIDE FUMARATE

IBUTILIDE FUMARATE was reported 31 times

IBUTILIDE FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOGLOBINAEMIA 1 0.0085
1 FEEDING TUBE COMPLICATION 1 0.0032
2 CSF TEST ABNORMAL 1 0.0020
3 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
4 TORSADE DE POINTES 6 0.0008
5 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
6 HYPERPHOSPHATAEMIA 1 0.0005
7 INFUSION SITE REACTION 1 0.0003
8 VENTRICULAR TACHYCARDIA 5 0.0003
9 ESCHERICHIA INFECTION 2 0.0002
10 BUNDLE BRANCH BLOCK LEFT 1 0.0002
11 ENTEROCOCCAL INFECTION 1 0.0002
12 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
13 DERMATITIS BULLOUS 1 0.0001
14 RENAL FAILURE CHRONIC 1 0.0001
15 FRUSTRATION TOLERANCE DECREASED 1 0.0001
16 SINUS BRADYCARDIA 1 0.0001
17 BREAST CANCER METASTATIC 1 0.0001
18 VENTRICULAR FIBRILLATION 1 0.0001
19 MYOCARDITIS 1 0.0001
20 NO THERAPEUTIC RESPONSE 1 0.0001
21 INCORRECT PRODUCT STORAGE 1 0.0001
22 SEASONAL ALLERGY 1 0.0001
23 DIALYSIS 1 0.0001
24 CARDIOGENIC SHOCK 1 0.0001
25 FLUID OVERLOAD 1 0.0001
26 COAGULOPATHY 1 0.0001
27 MULTI-ORGAN FAILURE 1 0.0001
28 TOOTHACHE 1 0.0001
29 HYPOCALCAEMIA 1 0.0001
30 MUSCULOSKELETAL DISORDER 1 0.0001
31 TASTE DISORDER 1 0.0000
32 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
33 ATRIAL FIBRILLATION 4 0.0000
34 EXPOSURE VIA SKIN CONTACT 1 0.0000
35 RESPIRATORY TRACT INFECTION 1 0.0000
36 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
37 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
38 HYPERKALAEMIA 1 0.0000
39 HYPERGLYCAEMIA 1 0.0000
40 BLINDNESS 1 0.0000
41 CARDIAC ARREST 2 0.0000
42 RHABDOMYOLYSIS 1 0.0000
43 POLLAKIURIA 1 0.0000
44 PULMONARY OEDEMA 1 0.0000
45 THERAPY NON-RESPONDER 1 0.0000
46 COMA 1 0.0000
47 MULTIPLE SCLEROSIS 1 0.0000
48 RENAL FAILURE 2 0.0000
49 NEUTROPENIA 2 0.0000
50 RESPIRATORY FAILURE 1 0.0000
51 UNEVALUABLE EVENT 1 0.0000
52 DRUG INTERACTION 2 0.0000
53 CARDIAC FAILURE CONGESTIVE 1 0.0000
54 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
55 MUSCULOSKELETAL STIFFNESS 1 0.0000
56 SUICIDAL IDEATION 1 0.0000
57 HYPOTENSION 2 0.0000
58 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
59 SEPSIS 1 0.0000
60 THROMBOCYTOPENIA 1 0.0000
61 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
62 LOSS OF CONSCIOUSNESS 1 0.0000
63 DEHYDRATION 1 0.0000
64 PRODUCT DOSE OMISSION ISSUE 2 0.0000
65 HOSPITALISATION 1 0.0000
66 TREMOR 1 0.0000
67 MUSCLE SPASMS 1 0.0000
68 ASTHENIA 2 0.0000
69 GAIT DISTURBANCE 1 0.0000
70 ABDOMINAL PAIN UPPER 1 0.0000
71 CONSTIPATION 1 0.0000
72 INCORRECT DOSE ADMINISTERED 1 0.0000
73 FEELING ABNORMAL 1 0.0000
74 INSOMNIA 1 0.0000
75 DYSPNOEA 2 0.0000
76 FATIGUE 1 0.0000